Rep. Rosa L. DeLauro

Maddy summaryThis House resolution marks the 25th anniversary of the September 11, 2001 terrorist attacks by formally honoring the memory of the nearly 3,000 victims and recognizing the sacrifices made by first responders, military personnel, and the passengers of United Airlines Flight 93. The bill acknowledges the ongoing health challenges faced by survivors and responders, highlighting the role of the World Trade Center Health Program in providing long-term medical support. It also credits charitable organizations and community groups that have continued to assist victims' families and veterans over the past two decades. Finally, the resolution urges the American public to observe the anniversary with ceremonies and reaffirms Congress's commitment to remembering the events and lessons of that day.

Maddy summaryHR 1869 creates a new DOJ task force within the Criminal Division to investigate and prosecute international trade crimes, such as customs evasion, smuggling, and trade-based money laundering. It requires the DOJ to hire specialized prosecutors, coordinate with agencies like U.S. Customs and Border Protection, and focus on specific violations covered under statutes like 18 U.S.C. §§ 541-546 and 21 U.S.C. § 331. The bill authorizes $20 million in funding for fiscal year 2026 (with 80% dedicated to criminal prosecutions), mandates annual reports to Congress on enforcement activities, and requires the DOJ to develop multi-agency partnerships to address these crimes. This directly affects federal prosecutors, border enforcement agencies, and industries impacted by trade violations.

Maddy summaryThe Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026 requires federal agencies to include reasonable pricing clauses in all research grants and contracts involving biomedical products. Under this provision, U.S. residents cannot be charged more than the median price found in Canada and six other high-income OECD countries for any drug, device, or therapy developed with federal support. The Secretary of Health and Human Services is authorized to establish additional regulations, such as mechanisms to lower prices when revenues exceed targets or costs per health benefit are too high, while retaining the ability to waive these obligations if doing so serves the public interest. To ensure accountability, manufacturers must report clinical trial costs, government subsidies, and annual revenues by county, with all data made publicly available.

Maddy summaryBaby Brent's Bill directs the Federal Trade Commission to investigate and regulate the advertising and marketing of formula designed for premature infants. The legislation requires the agency to create rules that prevent companies from hiding potential health risks or downplaying the differences between breast milk-based supplements and cow-based ones. These regulations would apply to manufacturers and importers of specialized infant formula intended for babies born before 37 weeks or with low birth weight. The bill aims to ensure parents receive clear information about product safety and options while maintaining the ability to seek legal recourse if their infants are harmed.

Maddy summaryThis bill establishes federal protections and funding to expand access to in vitro fertilization and intrauterine insemination for individuals, military service members, and veterans. It requires most private health plans, Medicaid programs, and Medicare to cover these fertility treatments without imposing higher cost-sharing than other medical services. Additionally, the legislation mandates that the Department of Defense and the Department of Veterans Affairs provide specific fertility preservation and treatment benefits to uniformed service members and eligible veterans. The bill also includes preemption clauses that override state laws restricting these procedures and prohibits discrimination based on marital status, sex, or sexual orientation in the provision of care.

Maddy summaryThis concurrent resolution formally recognizes the persistent wage gap between Black women and white, non-Hispanic men in the United States. It highlights data showing that Black women earn significantly less than their male counterparts and reaffirms Congress's support for existing laws that prohibit pay discrimination based on sex or race. The document does not create new laws or change policy but serves as a symbolic statement to raise awareness about the economic disparities faced by Black women.

Maddy summaryThe Americans vs. Poisonous Pesticides Act amends federal pesticide laws to allow state courts to hear lawsuits alleging that pesticide labels fail to warn about health or environmental risks. It clarifies that a pesticide's federal registration and label approval do not automatically block these state claims, though they serve as initial evidence of compliance. The bill also permits companies to update their product labels to address new safety information without waiting for prior government approval, subject to potential review by the agency. These changes apply to both new lawsuits and cases already in progress, ensuring that federal rules do not limit existing state legal remedies for damages or injunctive relief.

Maddy summaryThis bill establishes the INCLUDE Project at the National Institutes of Health (NIH) to advance research on Down syndrome and related health conditions. It requires NIH to fund high-risk studies on trisomy 21, support inclusive clinical trials for people with Down syndrome across all ages, and investigate co-occurring conditions like Alzheimer’s disease and autoimmunity. The law mandates NIH coordination across its institutes, consultation with patient advocates, and biennial reports to Congress detailing funded research and its real-world applications. The project directly affects individuals with Down syndrome, their families, and medical researchers, aiming to improve diagnosis, treatment, and quality of life through targeted scientific efforts.

Maddy summaryHR 2821, the FDA Modernization Act 3.0, requires the FDA to update regulatory language within one year of enactment. It directs the agency to replace all references to "animal tests" with "nonclinical tests" in 22 specific sections of the Code of Federal Regulations related to drug development and approval processes. The bill also adds a definition for "nonclinical test" into relevant FDA regulations to align with prior legislative changes. This update applies directly to pharmaceutical manufacturers and FDA reviewers who follow these regulatory guidelines during drug development. The changes aim to modernize terminology without altering current testing requirements.

Maddy summaryHR 2715, the *Destruction of Hazardous Imports Act*, expands the authority to destroy imported goods that pose public health risks. It amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary of Health and Human Services to order the destruction of any refused import (not just drugs or devices) if it presents a significant health concern. The bill also prohibits the unauthorized movement, sale, or export of such refused goods. These changes apply to importers of hazardous refused articles 180 days after enactment, with the FDA required to finalize implementing regulations within 90 days.